Oppenheimer Asset Management Inc. Karuna Therapeutics, Inc. Transaction History

Oppenheimer Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$161.01 - $317.85 $2,576 - $5,085	-16 Reduced 0.56%	2,845 $900,000
Q3 2023 Nov 07, 2023	SELL	$164.66 - $218.08 $1,646 - $2,180	-10 Reduced 0.35%	2,861 $483,000
Q2 2023 Aug 02, 2023	SELL	$176.32 - $240.22 $15,868 - $21,619	-90 Reduced 3.04%	2,871 $622,000
Q1 2023 May 10, 2023	BUY	$161.33 - $204.36 $149,875 - $189,850	929 Added 45.72%	2,961 $537,000
Q4 2022 Feb 06, 2023	BUY	$191.53 - $236.82 $92,700 - $114,620	484 Added 31.27%	2,032 $399,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $191,626 - $429,446	1,548 New	1,548 $348,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.